No Data
No Data
Estimating The Fair Value Of Stevanato Group S.p.A. (NYSE:STVN)
Stevanato Group to Present at Upcoming Investor Conference
Analysts Conflicted on These Healthcare Names: Pharvaris (PHVS) and Stevanato Group (STVN)
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $23
Morgan Stanley Reaffirms Their Hold Rating on Stevanato Group (STVN)